Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2013 | 2 |
2016 | 1 |
2019 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targeting the tumor microenvironment: JAK-STAT3 signaling.
JAKSTAT. 2013 Apr 1;2(2):e23828. doi: 10.4161/jkst.23828.
JAKSTAT. 2013.
PMID: 24058812
Free PMC article.
Review.
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors.
Gao SP, Chang Q, Mao N, Daly LA, Vogel R, Chan T, Liu SH, Bournazou E, Schori E, Zhang H, Brewer MR, Pao W, Morris L, Ladanyi M, Arcila M, Manova-Todorova K, de Stanchina E, Norton L, Levine RL, Altan-Bonnet G, Solit D, Zinda M, Huszar D, Lyden D, Bromberg JF.
Gao SP, et al. Among authors: bournazou e.
Sci Signal. 2016 Mar 29;9(421):ra33. doi: 10.1126/scisignal.aac8460.
Sci Signal. 2016.
PMID: 27025877
Free PMC article.
Item in Clipboard
Antitumorigenic potential of STAT3 alternative splicing modulation.
Zammarchi F, de Stanchina E, Bournazou E, Supakorndej T, Martires K, Riedel E, Corben AD, Bromberg JF, Cartegni L.
Zammarchi F, et al. Among authors: bournazou e.
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17779-84. doi: 10.1073/pnas.1108482108. Epub 2011 Oct 17.
Proc Natl Acad Sci U S A. 2011.
PMID: 22006329
Free PMC article.
Item in Clipboard
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.
Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X, Cotari J, Alpaugh ML, de Stanchina E, Manova K, Li M, Bonafe M, Ceccarelli C, Taffurelli M, Santini D, Altan-Bonnet G, Kaplan R, Norton L, Nishimoto N, Huszar D, Lyden D, Bromberg J.
Chang Q, et al. Among authors: bournazou e.
Neoplasia. 2013 Jul;15(7):848-62. doi: 10.1593/neo.13706.
Neoplasia. 2013.
PMID: 23814496
Free PMC article.
Item in Clipboard
Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma.
Dickinson M, Briones J, Herrera AF, González-Barca E, Ghosh N, Cordoba R, Rutherford SC, Bournazou E, Labriola-Tompkins E, Franjkovic I, Chesne E, Brouwer-Visser J, Lechner K, Brennan B, Nüesch E, DeMario M, Rüttinger D, Kornacker M, Hutchings M.
Dickinson M, et al. Among authors: bournazou e.
Blood Adv. 2021 Nov 23;5(22):4762-4770. doi: 10.1182/bloodadvances.2021004619.
Blood Adv. 2021.
PMID: 34581757
Free PMC article.
Clinical Trial.
Item in Clipboard
Vascular Adhesion Protein-1 (VAP-1) as Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis in the New York University Cohort.
Bournazou E, Samuels J, Zhou H, Krasnokutsky S, Patel J, Han T, Bencardino J, Rybak L, Abramson SB, Junker U, Brown KS, Attur M.
Bournazou E, et al.
Int J Mol Sci. 2019 May 29;20(11):2642. doi: 10.3390/ijms20112642.
Int J Mol Sci. 2019.
PMID: 31146362
Free PMC article.
Item in Clipboard
Cite
Cite